Atlas Trials

Efficacy and Safety Study of Ammonul® in Patients With Grade 3 or 4 Hepatic Encephalopathy

Clinical trial NCT00597909 · TERMINATED

Trial details

NCT number
NCT00597909
Sponsor
Amgen
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
Hepatic Encephalopathy
Start date
2007-12-01
Primary completion
2008-09-01
Enrollment
1

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.